Then, more studies delved into the expression profile of SBF2-AS1 among other cancers, including pancreatic cancer (PC) [27], hepatocellular carcinoma (HCC) [28, 29], colorectal cancer (CRC) [30], gastric cancer (GC) [31], esophageal squamous cell cancer(ESCC) [32–34], breast cancer (BC) [35], glioblastoma (GBM) [36, 37], and others [38–41]. Here, SBF2 is linked to breast carcinoma.